Advances in Cancer Research

Language: English

135.60 €

In Print (Delivery period: 14 days).

Add to cartAdd to cart
Publication date:
Support: Print on demand
Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of topics, including taxane-anti-androgens cross-resistance in advanced prostate cancer and proteasome inhibitors in the treatment of multiple myeloma.
1. Unravelling the Complexity and Functions of MTA Coregulators in Human CancerDa-Qiang Li, Rakesh Kumar2. Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic DatasetsManny D. Bacolod , Swadesh K. Das , Upneet K. Sokhi, Steven Bradley , David A. Fenstermacher , Maurizio Pellecchia, Luni Emdad, Devanand Sarkar and Paul B. Fisher 3. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer Sarah K. Martin and Natasha Kyprianou 4. Stem Cell-Based Therapies for Cancer Deepak Bhere and Khalid Shah5. Emerging Therapeutic Strategies for Overcoming Proteasome Inhibitor Resistance Nathan G. Dolloff6. Influence of Bone Marrow Microenvironment on Leukemic Stem Cells: Breaking up an Intimate RelationshipPuneet Agarwal and Ravi Bhatia7. Perspectives on Epidermal Growth Factor Receptor Regulation in Triple-negative Breast Cancer: Ligand-mediated Mechanisms of Receptor Regulation and Potential for Clinical TargetingCarly Bess Williams, Adam C. Soloff, Stephen P. Ethier, and Elizabeth S. Yeh8. The Quest for an Effective Treatment for an Intractable Cancer: Established and Novel Therapies for Pancreatic AdenocarcinomaBridget A. Quinn, Nathaniel A. Lee, Timothy P. Kegelman, Praveen Bhoopathi, Luni Emdad, Swadesh K. Das, Maurizio Pellecchia, Devanand Sarkar and Paul B. Fisher
  • Provides information on cancer research
  • Outstanding and original reviews
  • Suitable for researchers and students